Schizophrenia Is a Cognitive Illness: Time for a Change in Focus. by Kahn RS and Keefe RS. JAMA Psychiatry. 2013 Aug 7. doi: 10.1001/jamapsychiatry.2013.155. [Epub ahead of print] Schizophrenia is currently classified as a psychotic disorder. This article posits that this emphasis on psychosis is a conceptual fallacy that has greatly contributed to the lack […]
Antipsychotics: Taking the Long View NIMH Director’s Blog By Thomas Insel August 28, 2013 One of the first lessons I received as a psychiatrist-in-training 35 years ago was the value of antipsychotic medications. These medicines have been available for the treatment of psychosis for over half a century, beginning with the prototype first generation drug […]
I had weathered the massive changes in psychiatry I described in the last post pretty well I thought. I had learned that the people on my side of the street weren’t without sin and made a lot of changes of my own from what I learned. I still loved the profession I’d gravitated to even […]
In an earlier time [mid-1980s], I left academic medicine with the arrival of a new chairman. I’ve talked about that more than enough on this blog, but I want to mention just one thing from that time that seemed only a small part of my general confusion, but has turned out to be much larger […]
December 1, 1955…
I recently discussed a paper demonstrating a three-fold rise in the incidence of Diabetes in children taking Atypical Antipsychotics [what psychiatrists think…]. The cohort in that analysis came from the rolls of Tennessee Medicaid and the results were quite clear: In a comment to my post, Altostrata [Surviving Antidepressants] wrote… … What does it take […]
When I came to psychiatry, I was not drawn by the major disorders like Schizophrenia or Manic Depressive Illness. My experience with madness was like most, spotty from encounters in life – a Manic who wandered into a clothing store where I worked, a medical school classmate who had a psychotic break in our first […]
Eli Lilly says "deeply concerned" by bribery allegations in China Reuters Aug 22, 2013 U.S. drugmaker Eli Lilly and Co said it was "deeply concerned" about allegations published in a Chinese newspaper that it spent more than 30 million yuan ($4.90 million) to bribe doctors in China to prescribe the firm’s medicines instead of rival […]
Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth by William V. Bobo, William O. Cooper, C. Michael Stein, Mark Olfson, David Graham, James Daugherty, Catherine Fuchs, Wayne A. Ray JAMA Psychiatry. on-line first. August 21, 2013 Importance The increased prescribing of antipsychotics for children and youth has heightened concerns that […]